OCUMENSION THERAPEUTICS financial statements, including revenue, expenses, profit, and loss
The total revenue of 1477 for the last semiannual is 154.13 M HKD, and it's 31.43% higher compared to the previous semiannual. The net income of H2 23 is -185.15 M HKD.